Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, 809 Madu1-dong, Ilsan-gu, Goyang-si, Gyeonggi-do 411-769, South Korea.
World J Surg. 2013 Jan;37(1):214-9. doi: 10.1007/s00268-012-1783-x.
The purpose of the present study was to compare the direct costs of laparoscopic surgery (LS) and open surgery (OS) in the treatment of mid or low rectal cancer after preoperative chemoradiotherapy in patients in Korea.
The records of 130 LS patients and 125 OS patients were reviewed. Hospital stay after surgery and overall complication rates within three months of surgery were not significantly different. The LS group had significantly higher median costs than the OS group ($7,467.30 vs. $5,667.00; P < 0.001). The median hospital costs during hospitalization for surgery were higher in the LS group ($7,436.60 vs. $5,626.60; P < 0.001), but hospital costs for management of early postoperative complications were similar. The higher direct costs of LS were mainly due to the more expensive consumables and equipment needed for LS.
Further study is needed to determine whether the higher direct costs of LS for rectal cancer are balanced by advantages of LS over OS, such as better short-term outcomes and cosmetic effect.
本研究旨在比较韩国经术前放化疗治疗的中低位直肠癌患者中腹腔镜手术（LS）与开腹手术（OS）的直接成本。
回顾了 130 例 LS 患者和 125 例 OS 患者的记录。术后住院时间和术后三个月内的总并发症发生率无显著差异。LS 组的中位费用明显高于 OS 组（$7467.30 比 $5667.00；P < 0.001）。手术期间住院的中位手术医院费用 LS 组较高（$7436.60 比 $5626.60；P < 0.001），但术后早期并发症管理的医院费用相似。LS 较高的直接费用主要归因于 LS 所需的更昂贵的耗材和设备。
需要进一步研究 LS 治疗直肠癌的较高直接成本是否与 LS 优于 OS 的优势相平衡，例如更好的短期结果和美容效果。
